FDA approves higher dose of Wegovy

FDA approves higher dose of Wegovy

Health Care News – Read More The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg. The company says the higher dosage is recommended for those who taken the lower dose already for at least four weeks. Novo Nordisk… 

Early COVID-19 pandemic death toll much higher than official count: Study

Early COVID-19 pandemic death toll much higher than official count: Study

Health insurance jargon can be frustrating and confusing – here’s how to navigate it

Health insurance jargon can be frustrating and confusing – here’s how to navigate it